News headlines about China BAK Battery (NASDAQ:CBAK) have trended somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. China BAK Battery earned a news impact score of 0.12 on Accern’s scale. Accern also gave press coverage about the electronics maker an impact score of 45.5683267980639 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

China BAK Battery (NASDAQ:CBAK) opened at 1.50 on Monday. The firm has a 50-day moving average price of $1.42 and a 200 day moving average price of $1.39. China BAK Battery has a 52-week low of $1.20 and a 52-week high of $2.30. The stock’s market capitalization is $39.33 million.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact China BAK Battery (CBAK) Stock Price” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at

China BAK Battery Company Profile

CBAK Energy Technology, Inc, formerly China BAK Battery, Inc, is a holding company. The Company and its subsidiaries are engaged in the manufacture, commercialization and distribution of a range of standard and customized lithium ion (Li-ion) rechargeable batteries for use in an array of applications.

Insider Buying and Selling by Quarter for China BAK Battery (NASDAQ:CBAK)

Receive News & Stock Ratings for China BAK Battery Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China BAK Battery Inc. and related stocks with our FREE daily email newsletter.